Because Th17 cells are involved in the induction of certain autoimmune diseases and Tregs in suppressing such disorders, our studies suggest several key molecules such as miR-132 and HMGB1 as potential targets to treat such inflammatory disorders. The gene discussed is HMGB1; the disease is autoimmune disease.